Background HLA-G is an immune checkpoint molecule. Since a differential molecule
expression has been reported even for healthy individuals, many studies have focused on …

Objective To study the controversial association between human leukocyte antigen-G (HLA-
G) 14 bp polymorphism and recurrent pregnancy loss (RPL). We performed a meta-analysis …

Infertility is currently a growing problem observed around the world and is estimated to affect
between 8 and 12% of reproductive-aged couples worldwide. Artificial reproductive …

Purpose The human leucocyte antigen-G (HLA-G) 14-bp insertion/deletion polymorphism
was implicated in recurrent implantation failure (RIF), but individual published studies …

Introduction HLA-G plays a central role in immune tolerance at the maternal-fetal interface.
The HLA-G gene is characterized by low allelic polymorphism and restricted tissue …

The granted European patent EP 2 561 890 describes a procedure for an immunological
treatment of cancer. It is based on the principles of the HLA-supported communication of …

Background: The human leukocyte antigen-G (HLA-G) gene is highly expressed in cancer
pathologies and is one strategy used by tumor cells to escape immune surveillance. A 14-bp …

Problem The immune system plays an essential role in embryonic implantation and
pregnancy, but the molecular details remain controversial. In the past four decades, human …

Problem Human leukocyte antigen‐G (HLA‐G) expression is related to 14‐bp
insertion/deletion polymorphism at the 3′ UTR of the HLA‐G gene. Soluble forms of HLA‐G …

Idiopathic hypogonadotropic hypogonadism (IHH) is a condition caused by low doses of
hypothalamic gonadotropin-releasing hormone (GnRH) leading to absence or incomplete …